In this week’s Video Forum, Pano Anthos, founder and managing director of XRC Ventures, talks about the investment firm’s work in the retailing, health care technology and CPG industries. He discusses XRC’s investment strategy, the criteria it uses to decide which start-up and early stage companies to work with, and the sectors that he sees as ripe for innovation.
Video Forum: Pano Anthos, XRC Ventures
In this week’s Video Forum, Pano Anthos, founder and managing director of XRC Ventures, talks about the investment firm’s work in the retailing, health care technology and CPG industries.
Related
Kroger-Albertsons merger goes on trial in an Oregon federal court
The FTC faces off against lawyers from Albertsons and Kroger in a fight over competition in the grocery channel.
FDA approves Moderna’s updated COVID-19 vaccine
Moderna's updated COVID-19 vaccine targets the KP.2 variant of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older.
Kroger sues FTC, claims merger challenge violates Constitution
The company argues that by proceeding in its administrative tribunal, in addition to the separate action in federal court, the FTC is violating Constitutional protections.
CRN to Federal Appeals Court: NY AG’s arguments don’t support denial of preliminary injunction in NY age restrictions case
CRN’s most recent brief argues that the NY AG does not meaningfully address CRN’s arguments about the Act’s constitutional infirmities.
Latest
APhA highlights pharmacists' expertise at marijuana rescheduling ceremony
APhA believes that moving marijuana to Schedule III will help accelerate research into its medicinal applications and potentially lead to safer and more effective therapeutic uses.
Southeastern Grocers helping feed communities this holiday season
Grocer helps families unwrap hope and nourishment through community-powered giving campaigns.
CHPA applauds bill to accelerate OTC innovation
CHPA said the bill would boost OTC market innovation by clarifying and standardizing the review process for new and updated self-care products.
Novo Nordisk files FDA application for once-weekly obesity treatment
“The FDA submission of CagriSema marks an important milestone and signals a new era in weight management,” said Novo Nordisk CEO.